The ESMO AI & Digital Oncology Congress is the new forum organised by the European Society for Medical Oncology (ESMO) to provide an opportunity for scientific, methodological, regulatory, policy and industry experts to connect and interact, and to involve general cancer healthcare practitioners in discussions about AI and digital health. The Congress will involve all […]
This meeting is for UKBCG (UK Breast Cancer Group) members only. The UKBCG Annual Meeting is aimed at Consultant Oncologists but is also open to Oncology Associate Specialists and SpRs. Membership is open to UK-based individuals approved by the Trustees including: Consultant Clinical and Medical Oncologists Specialty doctors, postdoctoral research fellows, career registrars in clinical […]
We have assembled a combination of highly knowledgeable faculty members who will be talking on topics including, lung cancer screening, biomarker testing, systemic and local therapies in both NSCLC and SCLC. It will also involve discussions and debate on the pros and cons of treating oligometastatic NSCLC and put data in context with panel-based case-discussions. […]
The European Cancer Summit 2025 will unite the cancer community for an exceptional edition, fit for exceptional times. The Summit this year will focus on the urgent need to secure sustained political and financial support for cancer as a health and societal priority. This multistakeholder forum provides a unique setting for healthcare professionals, patients and […]
Overview This study day offers a comprehensive overview of surgical techniques for complex perineal reconstruction, including a multidisciplinary approach. It covers both reconstructive and resectional aspects of the field, including the role of radiology in preoperative planning and perioperative care. Lectures will discuss considerations in multi-organ removal and up to date avaiable reconstructive surgical options. […]
Following successful meetings from 2016 to 2024, we are delighted to continue this face-to-face meeting for our User Guide to Cancer Immunotherapy Conference in December 2025. Our updated programme will provide an overview of immunotherapy, with a focus on the recognition and management of immune-mediated toxicities. The meeting will have a strong clinical emphasis, aimed […]
Overview This multidisciplinary educational event brings together renowned experts and healthcare professionals to explore the rapidly evolving landscape of bladder cancer management. As one of the most common urological malignancies, bladder cancer presents unique challenges requiring coordinated care across multiple specialties. Our study day addresses critical developments in molecular diagnostics, emerging therapeutic approaches, and patient-centred […]
Overview This multidisciplinary educational event brings together renowned experts and healthcare professionals to explore the rapidly evolving landscape of bladder cancer management. As one of the most common urological malignancies, bladder cancer presents unique challenges requiring coordinated care across multiple specialties. Our study day addresses critical developments in molecular diagnostics, emerging therapeutic approaches, and patient-centred […]
This third session in the BAHNO MDT Interface Series focuses on the challenge of mental health in Head & Neck Cancer. It will explore how members of the MDT can recognise, discuss, and respond to mental health concerns in their patients. Key Topics • The relationship between mental health and head & neck cancer – […]
Save the date for the ESMO Immuno-Oncology Congress 2025, taking place from 10 until 12 December 2025 as an onsite event in London, UK, as well as online. This international event provides valuable knowledge: from basic science to translational research and clinical development, cutting-edge science, and excellent networking opportunities. Take part in this meeting to […]
HLH ccEvent Overview Date: 12 December 2025 Time: 9am - 5pm Venue: America Square, Cavendish Venues CPD: 6 credits A one-day in-person study day hosted by The HLH Imaging Group (HLH) focusing on the end-to-end process for lung cancer screening (LCS) in the UK. This programme brings together shared multidisciplinary learning from NHS Lung Cancer […]
Overview This study day will focus on important approaches to management of patients with secondary (or metastatic) breast cancer. Topics will include all aspects of the patient pathway, Including recent advances in systemic and local therapies for secondary breast cancer. There will also be sessions on the prevention and management of treatment toxicities. Target audience […]
